[CTXR] YoY Quarter Result on 30-Sep-2017 [#Q4]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
13-Dec-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q4]
Profit Trend
QoQ- -25.64%
YoY- -17.49%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -4,121 -3,650 -2,847 -3,043 -2,590 -908 -613 37.34%
Tax 24 12 822 784 5 -0 -10 -
NP -4,121 -3,650 -2,847 -3,043 -2,590 -908 -613 37.34%
Tax Rate - - - - - - - -
Total Cost 4,121 3,650 2,847 3,043 2,590 908 613 37.34%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.11 -0.18 -0.27 -0.56 -0.71 -0.43 -0.41 -19.67%
EPS Diluted -0.11 -0.18 -0.27 -0.56 -0.71 -0.43 -0.41 -19.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.